Drug Repositioning Discovery for Early- and Late-Stage  Non-Small-Cell Lung Cancer

<div class="floats-full-page floats-full-page-figure"><h2>Figure 3</h2><div class="floats-full-page-caption"><table>The upregulated target genes (circles) PPI partners (squares); solid line represents PPI.</table></div><div class="floats-full-page-content"><table class="table-group" width="800px"><tr class="fig-image"><td><img alt="193817.fig.003" src="https://static-01.hindawi.com/articles/bmri/volume-2014/193817/figures/193817.fig.003.jpg" /></td></tr></table></div></div>

Figure 3 | Drug Repositioning Discovery for Early- and Late-Stage  Non-Small-Cell Lung Cancer

title

Figure 3: Drug Repositioning Discovery for Early- and Late-Stage  Non-Small-Cell Lung Cancer

description

Figure 3

About this journal

<p><em>BioMed Research International</em> publishes original research articles, review articles, and clinical studies covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research.</p>


Journal profile

Meet the editorial board

<p><em>BioMed Research International</em> maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.</p>


Editor spotlight

Submit to Special Issue

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.

Special Issues

Author guidelines

Editorial board

Databases and indexing

BioMed Research International

About this Journal

Editorial Board

Peer Review Process

Publication Ethics

Abstracting and Indexing

Article Processing Charges

Journal overview

For authors

For reviewers

For editors

Open Special Issues

Published Special Issues

Propose Special Issue

About Special Issues